These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23745120)

  • 21. Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.
    Karczmarczyk M; Martins M; Quinn T; Leonard N; Fanning S
    Appl Environ Microbiol; 2011 Oct; 77(20):7113-20. PubMed ID: 21856834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of AcrEF in Quinolone Resistance Development in Escherichia coli When AcrAB-TolC Function Is Impaired.
    Zhang CZ; Chang MX; Yang L; Liu YY; Chen PX; Jiang HX
    Microb Drug Resist; 2018; 24(1):18-23. PubMed ID: 28520511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium.
    Sun Y; Dai M; Hao H; Wang Y; Huang L; Almofti YA; Liu Z; Yuan Z
    PLoS One; 2011; 6(8):e23471. PubMed ID: 21858134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of
    Chowdhury N; Suhani S; Purkaystha A; Begum MK; Raihan T; Alam MJ; Islam K; Azad AK
    Microbiol Insights; 2019; 12():1178636119889629. PubMed ID: 31839709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of marbofloxacin administration on the emergence of marbofloxacin-resistant E. coli in faecal flora of goats and elucidation of molecular basis of resistance.
    Bhardwaj P; Kaur G; Rampal S
    J Glob Antimicrob Resist; 2020 Jun; 21():116-123. PubMed ID: 32302733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
    Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X
    Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium.
    Olliver A; Vallé M; Chaslus-Dancla E; Cloeckaert A
    FEMS Microbiol Lett; 2004 Sep; 238(1):267-72. PubMed ID: 15336432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.
    Oethinger M; Kern WV; Jellen-Ritter AS; McMurry LM; Levy SB
    Antimicrob Agents Chemother; 2000 Jan; 44(1):10-3. PubMed ID: 10602715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131.
    Atac N; Kurt-Azap O; Dolapci I; Yesilkaya A; Ergonul O; Gonen M; Can F
    Curr Microbiol; 2018 Dec; 75(12):1661-1666. PubMed ID: 30283991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of AcrAB-TolC Efflux Pump in Mediating Fluoroquinolone Resistance in Naturally Occurring Salmonella Isolates from China.
    Shen J; Yang B; Gu Q; Zhang G; Yang J; Xue F; Shao J; Yi X; Jiang Y
    Foodborne Pathog Dis; 2017 Dec; 14(12):728-734. PubMed ID: 28926285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition.
    Langevin AM; El Meouche I; Dunlop MJ
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33328350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates.
    Becnel Boyd L; Maynard MJ; Morgan-Linnell SK; Horton LB; Sucgang R; Hamill RJ; Jimenez JR; Versalovic J; Steffen D; Zechiedrich L
    Antimicrob Agents Chemother; 2009 Jan; 53(1):229-34. PubMed ID: 18838594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of marA is remarkably increased from the early stage of development of fluoroquinolone-resistance in uropathogenic Escherichia coli.
    Yamasaki E; Yamada C; Jin X; Nair GB; Kurazono H; Yamamoto S
    J Infect Chemother; 2015 Feb; 21(2):105-9. PubMed ID: 25456896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
    Zheng J; Cui S; Meng J
    J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals.
    Liu X; Boothe DM; Thungrat K; Aly S
    Vet Microbiol; 2012 Dec; 161(1-2):159-68. PubMed ID: 22877517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance/fitness trade-off is a barrier to the evolution of MarR inactivation mutants in Escherichia coli.
    Praski Alzrigat L; Huseby DL; Brandis G; Hughes D
    J Antimicrob Chemother; 2021 Jan; 76(1):77-83. PubMed ID: 33089314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.
    Vinué L; Corcoran MA; Hooper DC; Jacoby GA
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1537-45. PubMed ID: 26711751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-Genome Sequence of Fluoroquinolone-Resistant Escherichia coli HUE1, Isolated in Hokkaido, Japan.
    Munby M; Fujiki J; Aoki K; Kawaguchi C; Nakamura K; Nakamura T; Sasaki M; Sato T; Usui M; Sawa H; Yokota SI; Tamura Y; Iwano H
    Microbiol Resour Announc; 2020 Nov; 9(46):. PubMed ID: 33184163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.